Although the amyloid cascade hypothesis posits Aβ accumulation as the initiating toxic event in AD, as reviewed by Hardy and Higgins (1992), the aggregation of tau, the other amyloid protein associated with AD, has drawn increased attention recently (Jouanne et al., 2017). Here, MAPT is linked to Alzheimer disease.